1. | blazefred | |
2. | eddiebaez | |
3. | arkadiuszbaransk | |
4. | dddimensions |
1. | blazefred | |
2. | eddiebaez | |
3. | arkadiuszbaransk | |
4. | dddimensions |
1. | dddimensions 09/29/2017 Very low priced... bright future.. |
2. | blazefred 01/26/2018 Goldman Sachs initiates as a neutral |
3. | eddiebaez 03/01/2018 Emergent BioSolutions Awarded One-Year CDC Contract Valued at $26 Million for Vaccinia Immune Globulin Program |
4. | blazefred 01/08/2018 Poor day for $EBS |
5. | dddimensions 02/26/2018 Emergent BioSolutions and Valneva initiate phase 1 clinical study to evaluate zika vaccine |
6. | dddimensions 05/29/2018 CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine |
7. | blazefred 09/30/2017 An interesting Biotech company. Anthrax vaccine and more. ' Numbers Revealed, Reaffirms Outlook {Link} |
8. | eddiebaez 09/29/2017 Creeping toward $45 |
9. | blazefred 02/27/2018 Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus |
10. | eddiebaez 02/26/2018 Seems they are trying to find the right balance. |